NUFLAM

Pays: Australie

Langue: anglais

Source: Department of Health (Therapeutic Goods Administration)

Ingrédients actifs:

glucosamine sulfate potassium chloride, Quantity: 667 mg (Equivalent: glucosamine sulfate, Qty 500 mg; Equivalent: potassium chloride, Qty 167 mg); shark chondroitin sulfate, Quantity: 278 mg (Equivalent: chondroitin sulfate, Qty 250 mg)

Disponible depuis:

Zifam Pinnacle Pty Ltd

forme pharmaceutique:

Capsule, hard

Composition:

Excipient Ingredients: Gelatin; calcium hydrogen phosphate dihydrate; sodium lauryl sulfate; magnesium stearate; colloidal anhydrous silica; microcrystalline cellulose; purified water; titanium dioxide; iron oxide yellow; quinoline yellow

Mode d'administration:

Oral

indications thérapeutiques:

Maintain/support general health and wellbeing ; Decrease/reduce/relieve mild joint aches and pains ; Decrease/reduce/relieve symptoms of mild arthritis/mild osteoarthritis ; Helps maintain/supports healthy joint cartilage growth/development/production ; Maintain/support joint health ; Maintain/support joint mobility/flexibility

Descriptif du produit:

Visual Identification: ; Container Type: Multiple containers

Statut de autorisation:

Listed

Date de l'autorisation:

2020-12-24